Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial-Reference-Cited by-同舟云学术

Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial

Published:2016-05 Issue:5 Volume:64 Page:1090-1098
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Lencioni Riccardo,Llovet Josep M.,Han Guohong,Tak Won Young,Yang Jiamei,Guglielmi Alfredo,Paik Seung Woon,Reig Maria,Kim Do Young,Chau Gar-Yang,Luca Angelo,del Arbol Luis Ruiz,Leberre Marie-Aude,Niu Woody,Nicholson Kate,Meinhardt Gerold,Bruix Jordi

Publisher

Elsevier BV

Subject

Hepatology

Reference48 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010;Lozano;Lancet,2012

3. Management of hepatocellular carcinoma: an update;Bruix;Hepatology,2011

4. European Association for the Study of the Liver; European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

5. Hepatocellular carcinoma;Forner;Lancet,2012

Cited by 579 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic Therapies for Hepatocellular Carcinoma in India;Journal of Clinical and Experimental Hepatology;2024-11

2. Current research status of transarterial therapies for hepatocellular carcinoma;World Journal of Gastrointestinal Oncology;2024-09-15

3. Phase I–IV Drug Trials on Hepatocellular Carcinoma in Asian Populations: A Systematic Review of Ten Years of Studies;International Journal of Molecular Sciences;2024-08-27

4. Liver Resection and Transplantation in the Era of Checkpoint Inhibitors;JHEP Reports;2024-08

5. TACE plus lenvatinib and tislelizumab for intermediate-stage hepatocellular carcinoma beyond up-to-11 criteria: a multicenter cohort study;Frontiers in Immunology;2024-07-26